GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » EBIT

Greenfern Industries (NZSE:GFI) EBIT : NZ$ Mil (TTM As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries EBIT?

Greenfern Industries's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2023 was NZ$-1.95 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Greenfern Industries's annualized ROC % for the quarter that ended in Mar. 2023 was -57.47%. Greenfern Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was -81.46%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


Greenfern Industries EBIT Historical Data

The historical data trend for Greenfern Industries's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenfern Industries EBIT Chart

Greenfern Industries Annual Data
Trend Mar22 Mar23
EBIT
-2.17 -1.95

Greenfern Industries Semi-Annual Data
Mar22 Mar23
EBIT -2.17 -1.95

Competitive Comparison of Greenfern Industries's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Greenfern Industries's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenfern Industries's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenfern Industries's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Greenfern Industries's EV-to-EBIT falls into.



Greenfern Industries EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was NZ$ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenfern Industries  (NZSE:GFI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Greenfern Industries's annualized ROC % for the quarter that ended in Mar. 2023 is calculated as:

ROC % (Q: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2022 ) + Invested Capital (Q: Mar. 2023 ))/ count )
=-1.752 * ( 1 - 0% )/( (2.921 + 3.176)/ 2 )
=-1.752/3.0485
=-57.47 %

where

Note: The Operating Income data used here is one times the annual (Mar. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Greenfern Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2022  Q: Mar. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.946/( ( (2.151 + max(-0.066, 0)) + (2.491 + max(0.136, 0)) )/ 2 )
=-1.946/( ( 2.151 + 2.627 )/ 2 )
=-1.946/2.389
=-81.46 %

where Working Capital is:

Working Capital(Q: Mar. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.042 + 0 + 0.275) - (0.383 + 0 + 0)
=-0.066

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.309 + 0.024 + 0.233) - (0.431 + 0 + -0.00099999999999989)
=0.136

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Greenfern Industries's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2023 )
=/4.717
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenfern Industries EBIT Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenfern Industries (NZSE:GFI) Business Description

Traded in Other Exchanges
N/A
Address
115 Queen Street, Level 8, General Capital House, Auckland, NTL, NZL, 1040
Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.